The Genetic Basis of Human DNA Replication Timing
人类 DNA 复制时间的遗传基础
基本信息
- 批准号:10543681
- 负责人:
- 金额:$ 7.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-05-01 至 2024-01-01
- 项目状态:已结题
- 来源:
- 关键词:AwardBiological AssayBiologyCellsChromosome MappingCommunicationDNA Replication TimingDNA SequenceDNA biosynthesisData SetDevelopmentElementsExperimental GeneticsGene ExpressionGene Expression RegulationGenesGeneticGenetic DiseasesGenetic VariationGenomeGenome StabilityGenomic approachHumanHuman GeneticsLinkMeasuresMolecularMutationNatureOther GeneticsRegulationS phaseSpecific qualifier valueUnited States National Institutes of HealthWorkcancer geneticsepigenomeepigenomicsgenetic approachgenome resourcegenome-widehuman DNAinsightnovelnovel strategiesprogramsspatiotemporalsuccesstumorigenesis
项目摘要
PROJECT SUMMARY / ABSTRACT
DNA replication follows a defined spatiotemporal program in which different parts of the genome replicate at
different times during S phase. The DNA replication timing program interfaces with genome regulation while
also influencing the genome’s stability and mutational landscape. Abnormal replication timing is associated
with genetic diseases and oncogenesis. Despite the importance of DNA replication regulation to cell and
organismal biology, we have very limited understanding of the DNA sequences and molecular mechanisms
that specify the eukaryotic DNA replication timing program. Similarly, it remains unclear how replication timing
control intersects with the regulation of gene expression and with the epigenome in general. My lab has, and
continues to, develop novel experimental and computational approaches for measuring genome-wide
replication timing. We also pioneered a unique approach of linking replication timing to human genetic variation
in order to reveal the sequence elements that control replication timing and study their mechanisms of action
(Koren et al., Cell 2014; Ding et al., Nature Communications 2021; NIH Director’s New Innovator Award DP2-
GM123495). In this MIRA application, we will: 1) generate a new dataset of human replication timing, the
largest so far, and use a computational approach to link replication timing to gene expression and epigenomic
regulation in a novel and powerful way. 2) Utilize our previous and concurrent replication timing genetic
mapping in order to experimentally edit DNA sequences controlling replication timing. This will be followed by
several epigenomic assays and genetic experiments that will reveal the mechanisms and consequences of
replication timing regulation. As part of this, we will also develop a new approach, “perturb-RT”, to
systematically screen for novel sequence elements controlling replication timing. 3) Continue our recent
success of profiling replication timing in single cells by jointly measuring replication timing and gene expression
in the same single cells. We will use this approach to study how replication timing and gene expression co-vary
during cellular differentiation. Our work will substantially contribute to the field of DNA replication timing and
beyond, by providing unprecedented genomic resources, introducing novel genetic and genomic approaches,
deciphering the genetic basis of human replication timing, and revealing new insights into replication timing
regulation and its consequences.
项目摘要 /摘要
DNA复制遵循定义的时空程序,其中基因组的不同部分在
在s阶段的不同时间。 DNA复制时间与基因组调节的接口,而
还影响基因组的稳定性和突变景观。异常复制时机是相关的
遗传疾病和肿瘤发生。尽管DNA复制对细胞的重要性很重要,并且
生物学,我们对DNA序列和分子机制的理解非常有限
指定了真核DNA复制时间计划。同样,还不清楚复制时间如何
对照与基因表达的调节和表观基因组的调节相交。我的实验室有,
继续,开发用于测量全基因组的新型实验和计算方法
复制时机。我们还开创了将复制时间与人遗传变异联系起来的独特方法
为了揭示控制复制时间和研究其作用机理的序列元素
(Koren等人,Cell 2014; Ding等人,自然通讯2021; NIH董事的新创新者奖DP2-
GM123495)。在此MIRA应用程序中,我们将:1)生成人类复制时机的新数据集,
迄今为止最大的,并使用一种计算方法将复制时间与基因表达和表观基因组联系起来
以一种新颖而有力的方式进行调节。 2)利用我们以前的和并发的复制正时通用
映射以实验编辑控制复制时间的DNA序列。接下来是
几种表观基因组学测定和基因实验将揭示机制和后果
复制正时调节。作为此的一部分,我们还将开发一种新方法“ witturb-rt”,以
系统地筛选了控制复制时间的新型序列元素。 3)继续我们的最新
通过共同测量复制时间和基因表达,单个细胞中分析复制时间的成功
在同一单元中。我们将使用这种方法来研究复制时机和基因表达共同变化
在细胞分化过程中。我们的工作将大大促进DNA复制时机的领域和
除了提供前所未有的基因组资源,引入了新的遗传和基因组方法,
解释人类复制时间的遗传基础,并揭示对复制时间的新见解
监管及其后果。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Amnon Koren其他文献
Amnon Koren的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
冬虫夏草抗菌肽的序列测定及其生物学功能研究
- 批准号:81803848
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
基于同位素稀释质谱技术的多酚类物质生物学标志物的测定研究
- 批准号:81301487
- 批准年份:2013
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
关节软骨损伤及修复生物学表达及影像定量测定的基础研究
- 批准号:81171312
- 批准年份:2011
- 资助金额:56.0 万元
- 项目类别:面上项目
登革病毒不同毒株重要生物学特性的研究及全基因序列的测定
- 批准号:30360101
- 批准年份:2003
- 资助金额:18.0 万元
- 项目类别:地区科学基金项目
PmDNT生物学活性测定及其在猪AR发病中的作用
- 批准号:39170586
- 批准年份:1991
- 资助金额:3.5 万元
- 项目类别:面上项目
相似海外基金
Oxidative Stress and Mitochondrial Dysfunction in Chemogenetic Heart Failure
化学遗传性心力衰竭中的氧化应激和线粒体功能障碍
- 批准号:
10643012 - 财政年份:2023
- 资助金额:
$ 7.63万 - 项目类别:
Prenatal Extracellular Vesicles and Steroid Hormones as Biological Mechanisms Underlying Gestational Factors Associated with Neurodevelopmental Risk
产前细胞外囊泡和类固醇激素作为与神经发育风险相关的妊娠因素的生物机制
- 批准号:
10739066 - 财政年份:2023
- 资助金额:
$ 7.63万 - 项目类别:
Understanding metabolic and vascular vulnerabilities of residual disease in triple negative breast cancer to inform on treatment strategies
了解三阴性乳腺癌残留疾病的代谢和血管脆弱性,为治疗策略提供信息
- 批准号:
10744480 - 财政年份:2023
- 资助金额:
$ 7.63万 - 项目类别: